According to the latest report by IMARC Group, titled “Europe Biopsy Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the Europe biopsy devices market size reached US$ 555 Million in 2022. Biopsy devices are specialized medical instruments designed to obtain tissue samples from the human body for diagnostic purposes. These devices play a crucial role in the early detection and accurate diagnosis of various medical conditions, including cancers and other diseases. They enable healthcare professionals to extract tissue samples in a minimally invasive (MI) manner, reducing patient discomfort and recovery time. Biopsy devices are available in various types, including needle-based, vacuum-assisted, and surgical biopsy tools, each catering to specific clinical requirements. These devices are integral to modern healthcare practices, aiding clinicians in making informed treatment decisions based on precise pathological insights.
Europe Biopsy Devices Market Trends:
The increasing prevalence of cancer and chronic diseases across the region, intensifying the demand for accurate and efficient diagnostic tools, is one of the major factors contributing to the market growth. In line with this, the growing application of biopsy devices for early detection, personalized treatment approaches, and providing precise tissue samples for analysis is propelling the market growth. Additionally, rapid technological advancements and innovations in biopsy techniques, such as image-guided biopsies and minimally invasive (MI) procedures, enhancing accuracy while reducing patient discomfort and risks are strengthening the market growth. Moreover, the growing emphasis on research and development (R&D) within the medical industry leading to the creation of biopsy devices that offer higher precision and better compatibility with various imaging modalities, particularly crucial in the field of oncology, is creating a positive outlook for the market growth. In addition to this, the growing focus of regulatory bodies on patient safety and device quality, prompting manufacturers to improve the safety and effectiveness of biopsy devices, resulting in cutting-edge technology and adherence to international standards, is fueling the market growth. Furthermore, the transition towards value-based healthcare and cost-effectiveness as healthcare systems in the region look for solutions that deliver accurate diagnoses efficiently and at a reasonable cost is providing a considerable boost to the market growth. Besides this, the launch of biopsy devices that offer high-quality samples, quicker turnaround times, and compatibility with modern diagnostic platforms are supporting the market growth. Looking forward, the market value is projected to reach US$ 831.3 Million by 2028, expanding at a CAGR of 6.9% during 2023-2028.
- Based on the procedure type, the market has been bifurcated as surgical and needle biopsy.
- On the basis of the product, the market has been divided into biopsy guidance systems, needle-based biopsy guns, biopsy needles, biopsy forceps and others.
- Based on the application, the market has been classified as breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy and others.
- On the basis of the guidance-technique, the market has been categorized as ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy and others.
- Based on the end-user, the market has been divided into hospitals and clinics, academic and research institutes and others.
- Country-wise, the market has been segmented into Germany, France, the United Kingdom, Italy, Spain and others.
- The competitive landscape of the market has also been examined along with the profile of the key players.
|Base Year of the Analysis
||Procedure Type, Product, Application, Guidance Technique, End User, Country
||Germany, France, United Kingdom, Italy, Spain, Others
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800